source
- GSK to invest up to $110 million in expanded AI drug-discovery partnership with Relation TherapeuticsGSK announced it will pay Relation Therapeutics up to $110 million to broaden their existing collaboration that uses artificial‑intelligence models to identify new drug candidates. The expanded ag…
- Regeneron and Sanofi explore expanded partnership for Dupixent follow-on candidatesRegeneron and Sanofi said they are in early discussions about expanding their collaboration beyond the existing Dupixent partnership. The companies indicated the potential scope could include deve…